hypericin has been researched along with Cancer of Esophagus in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypericin is a very promising new photosensitizer for innovative photodynamic therapy of esophageal cancer." | 1.32 | Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells. ( Höpfner, M; Kashtan, H; Lenz, M; Maaser, K; Riecken, EO; Scherübl, H; Sutter, AP; Theiss, A; von Lampe, B; Zeitz, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Höpfner, M | 1 |
| Maaser, K | 1 |
| Theiss, A | 1 |
| Lenz, M | 1 |
| Sutter, AP | 1 |
| Kashtan, H | 1 |
| von Lampe, B | 1 |
| Riecken, EO | 1 |
| Zeitz, M | 1 |
| Scherübl, H | 1 |
1 other study available for hypericin and Cancer of Esophagus
| Article | Year |
|---|---|
Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Anthracenes; Antineoplastic Agents; Apoptosis; Carcinoma, Squam | 2003 |